These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 916094)

  • 1. Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder.
    Banks MD; Pontes JE; Izbicki RM; Pierce JM
    J Urol; 1977 Nov; 118(5):757-60. PubMed ID: 916094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
    Horn Y; Eidelman A; Walach N; Yuval E; Markowitz A
    J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the intravesical action of topically administered G3H-doxorubicin hydrochloride in men: plasma uptake and tumor penetration.
    Jacobi GH; Kurth KH
    J Urol; 1980 Jul; 124(1):34-7. PubMed ID: 7411716
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma.
    Garnick MB; Schade D; Israel M; Maxwell B; Richie JP
    J Urol; 1984 Jan; 131(1):43-6. PubMed ID: 6690745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical instillation of doxorubicin hydrochloride and its incorporation into bladder tumors.
    Nakada T; Akiya T; Yoshikawa M; Koike H; Kayayama T
    J Urol; 1985 Jul; 134(1):54-7. PubMed ID: 4009823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of superficial transitional cell bladder carcinoma. Long-term results of trial comparing transurethral resection alone and adjuvant chemotherapy with Doxorubicin].
    Milonas D; Mickevicius J; Mickevicius R; Motiejūnas A; Sukys D; Gudinaviciene I
    Medicina (Kaunas); 2002; 38 Suppl 1():79-83. PubMed ID: 12556642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer.
    Cheng CW; Chan PS; Chan LW; Chan CK; Ng CF; Lai MM
    Int Braz J Urol; 2005; 31(3):204-11. PubMed ID: 15992422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH; Bouffioux C; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.
    Kurth KH; Schröder FH; Tunn U; Ay R; Pavone-Macaluso M; Debruyne F; de Pauw M; Dalesio O; ten Kate F
    J Urol; 1984 Aug; 132(2):258-62. PubMed ID: 6376827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
    Kurth KH; Debruyne FJ; Senge T; Carpentier PJ; Riedl H; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1985; 185B():135-42. PubMed ID: 3898138
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
    Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravesical chemotherapy of bladder cancer using adriamycin].
    Matveev BP; Shipilov VI; Romanov VA; Minakova LR; Gorilovskiĭ LM
    Urol Nefrol (Mosk); 1984; (5):6-9. PubMed ID: 6506387
    [No Abstract]   [Full Text] [Related]  

  • 13. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.
    Jauhiainen K; Alfthan O
    Ann Chir Gynaecol; 1984; 73(4):206-10. PubMed ID: 6508201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder.
    Jakse G; Hofstädter F; Marberger H
    J Urol; 1981 Feb; 125(2):185-90. PubMed ID: 7206051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What therapeutic approach should be adopted for superficial bladder tumours?
    Chatelain C
    Prog Clin Biol Res; 1984; 162B():211-8. PubMed ID: 6504896
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.
    Kurth K; Tunn U; Ay R; Schröder FH; Pavone-Macaluso M; Debruyne F; ten Kate F; de Pauw M; Sylvester R
    J Urol; 1997 Aug; 158(2):378-84. PubMed ID: 9224307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection: a prospective, randomized, multicenter study.
    Li NC; Ye ZQ; Na YQ;
    Chin Med J (Engl); 2013; 126(15):2805-9. PubMed ID: 23924446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early adjuvant adriamycin in superficial bladder carcinoma.
    Schulman CC; Denis LJ; Costerlinck W; De Sy W; Chantrie M; Bouffioux C; Van Cangh PJ; Van Erps P; De Sloover C
    Prog Clin Biol Res; 1984; 162B():151-62. PubMed ID: 6390444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical therapy with adriamycin in patients with superficial bladder tumors.
    Edsmyr F; Berlin T; Boman J; Duchek M; Esposti PL; Gustafsson H; Wijkström H; Collste LG
    Eur Urol; 1980; 6(3):132-6. PubMed ID: 7378141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical investigation on intravesical instillation of high-dose pirarubicin during perioperative period to prevent bladder carcinoma recurrence].
    Gao JG; Tian T; Song YL; Dong ZY; Yang XF
    Zhonghua Wai Ke Za Zhi; 2010 Nov; 48(21):1650-2. PubMed ID: 21211262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.